Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors (CERTUM)
Concordance Between Gynaecologic Sonography Amd Pelvic MRI for the Pre-surgical Diagnosis of Uterine Mesenchymal Malignant Tumors
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Terminated
Not enough patients included
Other terminated trials from Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Leiomyoma, Uterine · Dec 2019
- Polycystic Ovary Syndrome · Phase PHASE4 · May 2018
- Huntington Disease · Phase PHASE1 · May 2016
- Pneumococcal Meningitis · Phase PHASE4 · Dec 2015
- Blood Loss · Phase PHASE3 · May 2015
See all terminations from Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Listed as NCT02940041, this observational or N/A phase trial focuses on Leiomyoma and Leiomyosarcoma and remains terminated or withdrawn. Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, it has been updated 8 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2024 — Jul 2024 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Jan 2021 — Jan 2024 [monthly]
Unknown Status
-
Nov 2018 — Jan 2021 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.